$4.37
2.92% today
Nasdaq, Apr 25, 05:18 pm CET
ISIN
US09075F1075
Symbol
BNGO
Sector
Industry

BioNano Genomics, Inc. Stock price

$4.25
+0.95 28.79% 1M
-13.49 76.04% 6M
-13.05 75.44% YTD
-41.42 90.69% 1Y
-1,081.75 99.61% 3Y
-204.55 97.96% 5Y
-4,189.75 99.90% 10Y
Nasdaq, Closing price Thu, Apr 24 2025
+0.15 3.66%
ISIN
US09075F1075
Symbol
BNGO
Sector
Industry

Key metrics

Market capitalization $13.18m
Enterprise Value $20.00m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.65
P/S ratio (TTM) P/S ratio 0.43
P/B ratio (TTM) P/B ratio 0.22
Revenue growth (TTM) Revenue growth -14.79%
Revenue (TTM) Revenue $30.78m
EBIT (operating result TTM) EBIT $-86.31m
Free Cash Flow (TTM) Free Cash Flow $-70.77m
Cash position $20.48m
EPS (TTM) EPS $-91.86
P/E forward negative
P/S forward 0.43
EV/Sales forward 0.66
Short interest 19.56%
Show more

Is BioNano Genomics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,790 stocks worldwide.

BioNano Genomics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a BioNano Genomics, Inc. forecast:

1x Buy
33%
2x Hold
67%

Analyst Opinions

3 Analysts have issued a BioNano Genomics, Inc. forecast:

Buy
33%
Hold
67%

Financial data from BioNano Genomics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
31 31
15% 15%
100%
- Direct Costs 30 30
15% 15%
99%
0.38 0.38
96% 96%
1%
- Selling and Administrative Expenses 48 48
34% 34%
155%
- Research and Development Expense 25 25
54% 54%
81%
-72 -72
38% 38%
-234%
- Depreciation and Amortization 14 14
4% 4%
46%
EBIT (Operating Income) EBIT -86 -86
34% 34%
-280%
Net Profit -112 -112
52% 52%
-364%

In millions USD.

Don't miss a Thing! We will send you all news about BioNano Genomics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BioNano Genomics, Inc. Stock News

Neutral
GlobeNewsWire
2 days ago
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a peer-reviewed publication in Genome Research demonstrating that optical genome Mapping (OGM) can be an accurate, cost-effective method for detecting and sizing large repeat expansions, which are a class of structural variation (SV) linked to as many as 40 genetic disorders. Led by Alexander Hoi...
Neutral
GlobeNewsWire
17 days ago
SAN DIEGO, April 08, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a study published in The Journal of Molecular Diagnostics that describes a method for analysis of multiple myeloma (MM) by optical genome mapping (OGM). MM is one of the most common blood cancers, or hematologic malignancies, and is understood to be a difficult sample to analyze using traditional...
Neutral
Seeking Alpha
25 days ago
Bionano Genomics, Inc. (NASDAQ:BNGO ) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ET Company Participants David Holmes - IR Erik Holmlin - CEO and Principal Financial Officer Conference Call Participants Sung Ji Nam - Scotiabank Operator Good day, and welcome to the Bionano Fourth Quarter 2024 Earnings Conference Call. Today's conference is being recorded.
More BioNano Genomics, Inc. News

Company Profile

BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. The company was founded by Han Cao in October 2003 and is headquartered in San Diego, CA.

Head office United States
CEO Robert Holmlin
Employees 100
Founded 2003
Website www.bionano.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today